Robotic-Assisted Orthopedic Surgery System Market Size, Share, and Trends Analysis - Global - 2025-2031 - Includes: Capital Equipment Market, Disposables and Other Accessories Market, and 1 more
Description
Global Robotic-Assisted Orthopedic Surgery System Market Report, 2025 Edition
Executive Summary
The global robotic-assisted orthopedic surgery system market was valued at approximately 1.3 billion dollars in 2024. The market is expected to grow at a strong compound annual growth rate of 17.1 percent, reaching nearly 3.9 billion dollars by 2031. Growth is being driven by the rapid expansion of robotic-assisted large joint replacements, accelerated adoption in high-volume orthopedic centers and increasing clinical validation for robotic approaches in knee, hip and emerging shoulder procedures.
This report includes capital equipment, disposables and other accessories, and service and maintenance revenue. It quantifies units, average selling prices, market values, growth rates and competitive shares, and it analyzes key market drivers and limiters, technological advancements, recent mergers and acquisitions and adoption trends across major orthopedic specialties. It provides historical data to 2022 and forecasts to 2032. The scope reflects how hospitals evaluate robotic platforms, imaging compatibility, surgical planning features, workflow efficiency and broadening indications in total knee, partial knee, total hip and upcoming shoulder applications.
Market Overview
Robotic-assisted orthopedic surgery has become one of the fastest-growing segments in global MedTech. By 2024, more than half a million orthopedic procedures worldwide had been performed using a robotic system, and adoption continues to accelerate. Orthopedic robotics is driven by strong patient demand for minimally invasive and highly precise procedures, improved clinical outcomes and expanding insurance coverage for robotic-assisted joint replacement.
Large joint replacement procedures, particularly total knee replacement, form the core of the market. Orthopedic manufacturers have concentrated their innovation efforts on this high-value segment, while also extending robotic capabilities to hips and shoulders. In 2024, Zimmer Biomet received U.S. FDA clearance for the ROSA Shoulder System and completed its first procedures. Stryker is also preparing the expansion of its Mako platform to shoulder applications. These developments signal that shoulder robotics will emerge as the next high-growth subsegment.
Unlike some other surgical robotics markets, where procedure volumes remain limited, orthopedic robotics is supported by a large installed base, strong surgeon training programs and increasing hospital investment in digital surgery ecosystems. As demographic pressures and orthopedic procedure demand rise globally, robotic-assisted orthopedic systems are expected to play an increasingly central role in high-volume joint replacement workflows.
Market Drivers
Clinical and Economic Benefits
Robotic-assisted orthopedic systems offer more accurate implant placement, improved bone preparation and detailed preoperative and intraoperative planning tools. These advantages reduce complication rates, minimize postoperative pain and shorten recovery times. A published study from 2018 demonstrated reduced hospital stay durations after robotic-assisted total hip replacement compared with conventional surgery. Similar findings were reported in 2022 for robotic-assisted total knee replacement, further validating the economic value of robotics for hospitals and payors.
As hospitals continue to prioritize outcome improvements and cost reduction, these clinical and economic benefits will play a central role in driving adoption in both established and emerging markets.
Increasing Number of Procedures
Global procedure volumes for total knee, partial knee and total hip replacements are expected to rise substantially over the next decade due to a growing elderly population and an expanding working-age population seeking earlier surgical intervention. While not all procedures use robotic assistance, the proportion completed with robotic systems increases each year.
Robotic adoption rates are influenced by expanded availability of platforms, greater surgeon familiarity and broader reimbursement coverage. As more systems enter the market, including those at lower price points, the total number of robotic-assisted orthopedic procedures will continue to rise.
Focus on Total Knee Application
Total knee replacement is the largest and fastest-growing application in orthopedic robotics. Manufacturers have aligned their development strategies with this high-value segment, ensuring that robotic platforms support comprehensive knee workflows. Many companies have already launched robotic total knee capabilities, while others have announced plans to enter the segment over the coming years.
This competitive push will inevitably increase the number of robotic-assisted total knee procedures, as hospitals look to remain competitive, improve patient-reported outcomes and support surgeon demand for advanced planning and navigation tools.
Growth of Shoulder Robotics
Shoulder replacement procedures are gaining interest in orthopedic robotics due to the complexity of glenoid positioning and implant alignment. With Zimmer Biomet’s ROSA Shoulder receiving FDA clearance in 2024, the market has entered a new phase of expansion beyond hips and knees. Early adopters have already reported successful robotic shoulder procedures, and additional systems from competing manufacturers are expected to launch in the near future. This development will support the next wave of robotic growth.
Market Limiters
Procedure Times
Robotic-assisted orthopedic procedures often require additional steps, such as registration, imaging integration and preoperative planning. The Mako system, for example, is CT based and requires preoperative planning, which increases preparation time but improves implant accuracy. Other systems use preoperative registration and intraoperative navigation, which add time and introduce the potential for error.
Extended operating times can reduce the number of daily procedures, increasing the facility’s cost per case and creating hesitancy among surgeons who are unfamiliar with the systems.
Contradicting Studies
While many studies show improved accuracy and outcomes with robotic-assisted orthopedic procedures, clinical evidence is not universally aligned. Some studies indicate minimal differences between robotic-assisted and conventional techniques in certain scenarios. These conflicting results affect hospital purchasing decisions, especially when systems require high upfront capital investment.
Cost of Using Robotic Systems
Robotic platforms carry high acquisition costs, and ongoing expenses include disposables, system maintenance and service contracts. Hospitals must allocate budget for training, equipment integration and imaging compatibility. As competing systems enter the market, pricing pressure may increase, but for now, cost remains a major barrier for facilities with limited budgets.
Regulatory Requirements
Robotics is subject to rigorous global regulatory standards. FDA approvals, CE certifications and country-specific evaluations can delay system launches and limit the speed of indication expansion. Regulatory hurdles particularly affect newer companies seeking to broaden the clinical utility of their systems.
Market Coverage and Data Scope
Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.
Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT for leading competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
Time frame: Base year 2024, forecasts to 2031, historical data 2021–2023.
Data sources: Primary interviews with orthopedic industry leaders, surgeon surveys, regulatory data, hospital procurement databases, and iData Research’s internal MedTech repository.
Method note: Market revenue is modeled as units × ASP, validated with procedural data and replacement cycle assumptions
Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers (ASCs) across major global regions.
Markets Covered and Segmentation
Robotic-Assisted Orthopedic Surgery Market
Further Segmented Into:
Revenue Type: Capital Equipment, Disposables and Other Accessories, Service and Maintenance Revenue
Competitive Analysis
Stryker
Stryker led the global robotic-assisted orthopedic surgery system market in 2024, driven by its Mako robotic platform. Mako has been used in well over half a million procedures globally and remains the most widely adopted robotic joint replacement system. Its presence across total knee, partial knee and total hip procedures provides Stryker with strong recurring revenue from disposables and service contracts.
Stryker’s portfolio also includes the NAV3i and NavSuite 3 navigation systems, extending the company’s presence into navigation technologies.
Smith and Nephew
Smith and Nephew held the second-leading position in 2024. The company offers two robotic platforms, NAVIO and CORI, with CORI representing the next generation of technology. NAVIO is being phased out as CORI adoption increases. Smith and Nephew also participates in the orthopedic navigation system market, giving it presence across both enabling technologies.
Zimmer Biomet
Zimmer Biomet offers a growing suite of robotic systems in its ROSA portfolio, including ROSA Knee, ROSA Partial Knee and ROSA Hip. In 2024, the company also received FDA clearance for the ROSA Shoulder system and completed its first clinical procedures. Zimmer Biomet’s expansion into shoulder robotics positions it for accelerated growth over the next several years.
Technology and Practice Trends
Robotic-assisted orthopedic surgery continues to evolve as hospitals and surgeons integrate digital tools into joint replacement workflows. Several major technology and practice trends are shaping the market and influencing purchasing decisions.
Expansion of Robotic Capabilities Across Multiple Joints
Robotic-assisted systems were initially adopted for knee procedures, but their clinical applications have expanded across total hip, partial knee and more recently shoulder surgery. The launch of systems such as Zimmer Biomet’s ROSA Shoulder and the anticipated expansion of Stryker’s Mako platform into shoulder indications reflect a growing trend toward multi-joint robotic ecosystems. Manufacturers are investing in platforms that support several types of large joint procedures from a single console, allowing hospitals to broaden procedural use and generate higher returns on system investment.
Integration with Digital Surgery Ecosystems
Modern systems incorporate advanced preoperative planning software, intraoperative alignment tools and improved real-time visualization. Digital templating, automated implant sizing and data-driven planning are becoming expected features. As platforms evolve, surgeons gain access to more accurate planning models and improved intraoperative guidance. These tools help standardize procedures, reduce variability and improve overall surgical precision, supporting long-term adoption.
Shift Toward Smaller and More Mobile Systems
Some companies are developing more compact or modular robotic platforms to improve operating room efficiency. Smaller systems reduce footprint constraints and allow repositioning between rooms. This trend supports adoption among facilities with limited space or high case volume, including smaller community hospitals and private centers.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
This report is essential for companies that need clear answers to key strategic questions, including:
Which robotic-assisted orthopedic surgery segments are growing the fastest
How competitive positioning is shifting as new systems enter the market
Which revenue streams, including disposables and service contracts, create the strongest long-term value
How surgeon adoption patterns vary across regions
How regulatory timelines and clinical data trends affect market entry and expansion
Which orthopedic applications offer the strongest growth opportunities over the next decade
The report provides a complete view of procedure volumes, pricing trends, competitive shares and technology integration pathways, helping commercial, strategy and investment teams make informed decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global robotic-assisted orthopedic surgery system market was valued at approximately 1.3 billion dollars in 2024. The market is expected to grow at a strong compound annual growth rate of 17.1 percent, reaching nearly 3.9 billion dollars by 2031. Growth is being driven by the rapid expansion of robotic-assisted large joint replacements, accelerated adoption in high-volume orthopedic centers and increasing clinical validation for robotic approaches in knee, hip and emerging shoulder procedures.
This report includes capital equipment, disposables and other accessories, and service and maintenance revenue. It quantifies units, average selling prices, market values, growth rates and competitive shares, and it analyzes key market drivers and limiters, technological advancements, recent mergers and acquisitions and adoption trends across major orthopedic specialties. It provides historical data to 2022 and forecasts to 2032. The scope reflects how hospitals evaluate robotic platforms, imaging compatibility, surgical planning features, workflow efficiency and broadening indications in total knee, partial knee, total hip and upcoming shoulder applications.
Market Overview
Robotic-assisted orthopedic surgery has become one of the fastest-growing segments in global MedTech. By 2024, more than half a million orthopedic procedures worldwide had been performed using a robotic system, and adoption continues to accelerate. Orthopedic robotics is driven by strong patient demand for minimally invasive and highly precise procedures, improved clinical outcomes and expanding insurance coverage for robotic-assisted joint replacement.
Large joint replacement procedures, particularly total knee replacement, form the core of the market. Orthopedic manufacturers have concentrated their innovation efforts on this high-value segment, while also extending robotic capabilities to hips and shoulders. In 2024, Zimmer Biomet received U.S. FDA clearance for the ROSA Shoulder System and completed its first procedures. Stryker is also preparing the expansion of its Mako platform to shoulder applications. These developments signal that shoulder robotics will emerge as the next high-growth subsegment.
Unlike some other surgical robotics markets, where procedure volumes remain limited, orthopedic robotics is supported by a large installed base, strong surgeon training programs and increasing hospital investment in digital surgery ecosystems. As demographic pressures and orthopedic procedure demand rise globally, robotic-assisted orthopedic systems are expected to play an increasingly central role in high-volume joint replacement workflows.
Market Drivers
Clinical and Economic Benefits
Robotic-assisted orthopedic systems offer more accurate implant placement, improved bone preparation and detailed preoperative and intraoperative planning tools. These advantages reduce complication rates, minimize postoperative pain and shorten recovery times. A published study from 2018 demonstrated reduced hospital stay durations after robotic-assisted total hip replacement compared with conventional surgery. Similar findings were reported in 2022 for robotic-assisted total knee replacement, further validating the economic value of robotics for hospitals and payors.
As hospitals continue to prioritize outcome improvements and cost reduction, these clinical and economic benefits will play a central role in driving adoption in both established and emerging markets.
Increasing Number of Procedures
Global procedure volumes for total knee, partial knee and total hip replacements are expected to rise substantially over the next decade due to a growing elderly population and an expanding working-age population seeking earlier surgical intervention. While not all procedures use robotic assistance, the proportion completed with robotic systems increases each year.
Robotic adoption rates are influenced by expanded availability of platforms, greater surgeon familiarity and broader reimbursement coverage. As more systems enter the market, including those at lower price points, the total number of robotic-assisted orthopedic procedures will continue to rise.
Focus on Total Knee Application
Total knee replacement is the largest and fastest-growing application in orthopedic robotics. Manufacturers have aligned their development strategies with this high-value segment, ensuring that robotic platforms support comprehensive knee workflows. Many companies have already launched robotic total knee capabilities, while others have announced plans to enter the segment over the coming years.
This competitive push will inevitably increase the number of robotic-assisted total knee procedures, as hospitals look to remain competitive, improve patient-reported outcomes and support surgeon demand for advanced planning and navigation tools.
Growth of Shoulder Robotics
Shoulder replacement procedures are gaining interest in orthopedic robotics due to the complexity of glenoid positioning and implant alignment. With Zimmer Biomet’s ROSA Shoulder receiving FDA clearance in 2024, the market has entered a new phase of expansion beyond hips and knees. Early adopters have already reported successful robotic shoulder procedures, and additional systems from competing manufacturers are expected to launch in the near future. This development will support the next wave of robotic growth.
Market Limiters
Procedure Times
Robotic-assisted orthopedic procedures often require additional steps, such as registration, imaging integration and preoperative planning. The Mako system, for example, is CT based and requires preoperative planning, which increases preparation time but improves implant accuracy. Other systems use preoperative registration and intraoperative navigation, which add time and introduce the potential for error.
Extended operating times can reduce the number of daily procedures, increasing the facility’s cost per case and creating hesitancy among surgeons who are unfamiliar with the systems.
Contradicting Studies
While many studies show improved accuracy and outcomes with robotic-assisted orthopedic procedures, clinical evidence is not universally aligned. Some studies indicate minimal differences between robotic-assisted and conventional techniques in certain scenarios. These conflicting results affect hospital purchasing decisions, especially when systems require high upfront capital investment.
Cost of Using Robotic Systems
Robotic platforms carry high acquisition costs, and ongoing expenses include disposables, system maintenance and service contracts. Hospitals must allocate budget for training, equipment integration and imaging compatibility. As competing systems enter the market, pricing pressure may increase, but for now, cost remains a major barrier for facilities with limited budgets.
Regulatory Requirements
Robotics is subject to rigorous global regulatory standards. FDA approvals, CE certifications and country-specific evaluations can delay system launches and limit the speed of indication expansion. Regulatory hurdles particularly affect newer companies seeking to broaden the clinical utility of their systems.
Market Coverage and Data Scope
Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.
Qualitative coverage: Growth trends, market limiters, competitive analysis, SWOT for leading competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
Time frame: Base year 2024, forecasts to 2031, historical data 2021–2023.
Data sources: Primary interviews with orthopedic industry leaders, surgeon surveys, regulatory data, hospital procurement databases, and iData Research’s internal MedTech repository.
Method note: Market revenue is modeled as units × ASP, validated with procedural data and replacement cycle assumptions
Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers (ASCs) across major global regions.
Markets Covered and Segmentation
Robotic-Assisted Orthopedic Surgery Market
Further Segmented Into:
Revenue Type: Capital Equipment, Disposables and Other Accessories, Service and Maintenance Revenue
Competitive Analysis
Stryker
Stryker led the global robotic-assisted orthopedic surgery system market in 2024, driven by its Mako robotic platform. Mako has been used in well over half a million procedures globally and remains the most widely adopted robotic joint replacement system. Its presence across total knee, partial knee and total hip procedures provides Stryker with strong recurring revenue from disposables and service contracts.
Stryker’s portfolio also includes the NAV3i and NavSuite 3 navigation systems, extending the company’s presence into navigation technologies.
Smith and Nephew
Smith and Nephew held the second-leading position in 2024. The company offers two robotic platforms, NAVIO and CORI, with CORI representing the next generation of technology. NAVIO is being phased out as CORI adoption increases. Smith and Nephew also participates in the orthopedic navigation system market, giving it presence across both enabling technologies.
Zimmer Biomet
Zimmer Biomet offers a growing suite of robotic systems in its ROSA portfolio, including ROSA Knee, ROSA Partial Knee and ROSA Hip. In 2024, the company also received FDA clearance for the ROSA Shoulder system and completed its first clinical procedures. Zimmer Biomet’s expansion into shoulder robotics positions it for accelerated growth over the next several years.
Technology and Practice Trends
Robotic-assisted orthopedic surgery continues to evolve as hospitals and surgeons integrate digital tools into joint replacement workflows. Several major technology and practice trends are shaping the market and influencing purchasing decisions.
Expansion of Robotic Capabilities Across Multiple Joints
Robotic-assisted systems were initially adopted for knee procedures, but their clinical applications have expanded across total hip, partial knee and more recently shoulder surgery. The launch of systems such as Zimmer Biomet’s ROSA Shoulder and the anticipated expansion of Stryker’s Mako platform into shoulder indications reflect a growing trend toward multi-joint robotic ecosystems. Manufacturers are investing in platforms that support several types of large joint procedures from a single console, allowing hospitals to broaden procedural use and generate higher returns on system investment.
Integration with Digital Surgery Ecosystems
Modern systems incorporate advanced preoperative planning software, intraoperative alignment tools and improved real-time visualization. Digital templating, automated implant sizing and data-driven planning are becoming expected features. As platforms evolve, surgeons gain access to more accurate planning models and improved intraoperative guidance. These tools help standardize procedures, reduce variability and improve overall surgical precision, supporting long-term adoption.
Shift Toward Smaller and More Mobile Systems
Some companies are developing more compact or modular robotic platforms to improve operating room efficiency. Smaller systems reduce footprint constraints and allow repositioning between rooms. This trend supports adoption among facilities with limited space or high case volume, including smaller community hospitals and private centers.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
This report is essential for companies that need clear answers to key strategic questions, including:
Which robotic-assisted orthopedic surgery segments are growing the fastest
How competitive positioning is shifting as new systems enter the market
Which revenue streams, including disposables and service contracts, create the strongest long-term value
How surgeon adoption patterns vary across regions
How regulatory timelines and clinical data trends affect market entry and expansion
Which orthopedic applications offer the strongest growth opportunities over the next decade
The report provides a complete view of procedure volumes, pricing trends, competitive shares and technology integration pathways, helping commercial, strategy and investment teams make informed decisions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
123 Pages
- Research Methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems And Perform Secondary Research
- Step 3: Preparation For Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast And Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review And Market Release
- Step 9: Customer Feedback And Market Monitoring
- Disease Overview
- 2.1 Medical Conditions
- 2.1.1 Cardiac Conditions
- 2.1.1.1 Coronary Artery Disease
- 2.1.1.2 Mitral Valve Prolapse
- 2.1.2 Colorectal Conditions
- 2.1.2.1 Colorectal Cancer
- 2.1.2.2 Diverticulitis
- 2.1.2.3 Inflammatory Bowel Disease
- 2.1.3 Digestive Tract Conditions
- 2.1.3.1 Achalasia
- 2.1.3.2 Gallbladder Attack
- 2.1.3.3 Gastroesophageal Reflux Disease
- 2.1.3.4 Hernia
- 2.1.3.5 Stomach Cancer
- 2.1.4 Ear, Nose And Throat (Ent) Conditions
- 2.1.4.1 Cholesteatomas
- 2.1.4.2 Chronic Sinusitis
- 2.1.4.3 Otitis Media
- 2.1.4.4 Otosclerosis
- 2.1.4.5 Tonsillitis
- 2.1.5 Gynecological Conditions
- 2.1.5.1 Endometriosis
- 2.1.5.2 Gynecological Cancers
- 2.1.5.3 Menorrhagia
- 2.1.5.4 Pelvic Prolapse
- 2.1.5.5 Uterine Fibroids
- 2.1.6 Neurosurgical Conditions
- 2.1.6.1 Brain Tumor
- 2.1.6.2 Communicating Hydrocephalus
- 2.1.6.3 Hydrocephalus
- 2.1.6.4 Intracranial Aneurysm
- 2.1.6.5 Intracranial Atherosclerosis Disease
- 2.1.6.6 Intracranial Pressure
- 2.1.6.7 Non-Communicating Hydrocephalus
- 2.1.6.8 Normal Pressure Hydrocephalus
- 2.1.7 Orthopedic Conditions
- 2.1.7.1 Arthritis
- 2.1.7.2 Fractures
- 2.1.7.3 Osteoporosis
- 2.1.8 Spinal Conditions
- 2.1.8.1 Herniated Disc
- 2.1.8.2 Kyphosis
- 2.1.8.3 Scoliosis
- 2.1.8.4 Spinal Stenosis
- 2.1.8.5 Spondylosis
- 2.1.9 Urological Conditions
- 2.1.9.1 Benign Prostatic Hyperplasia (Bph)
- 2.1.9.2 Bladder Cancer
- 2.1.9.3 Kidney Cancer
- 2.1.9.4 Prostate Cancer
- Robotic-Assisted Orthopedic Surgery System Market
- 11.1 Executive Summary
- 11.1.1 Global Robotic-Assisted Orthopedic Surgery System Market Overview
- 11.1.2 Competitive Analysis
- 11.1.3 Procedure Segmentation
- 11.1.4 Market Segmentation
- 11.1.5 Regions Included
- 11.2 Introduction
- 11.3 Procedure Numbers
- 11.3.1 Robotic-Assisted Total Knee Arthroplasty (Tka) Orthopedic Procedures
- 11.3.2 Robotic-Assisted Partial Knee Arthroplasty (Pka) Orthopedic Procedures
- 11.3.3 Robotic-Assisted Total Hip Arthroplasty (Tha) Orthopedic Procedures
- 11.4 Market Overview
- 11.4.1 By Segment
- 11.4.2 By Region
- 11.5 Market Analysis And Forecast
- 11.5.1 System Placement
- 11.5.2 Robotic-Assisted Orthopedic Capital Equipment Market
- 11.5.3 Robotic-Assisted Orthopedic Surgery Disposables And Other Accessories Market
- 11.5.4 Robotic-Assisted Orthopedic Surgery System Service And Maintenance Revenue Market
- 11.6 Drivers And Limiters
- 11.6.1 Market Drivers
- 11.6.2 Market Limiters
- 11.7 Competitive Market Share Analysis
- Abbreviations
- Chart 11-1: Robotic-Assisted Orthopedic Surgery System Market, Global, 2024 & 2031
- Chart 11-2: Robotic-Assisted Orthopedic Surgery System Procedures, Global, 2024
- Chart 11-3: Robotic-Assisted Orthopedic Surgery Procedures by Region, Global, 2021 – 2031
- Chart 11-4: Robotic-Assisted Orthopedic Surgery System Market by Segment, Global, 2021 – 2031
- Chart 11-5: Robotic-Assisted Orthopedic Surgery System Market by Region, Global, 2021 – 2031
- Chart 11-6: Leading Competitors, Robotic-Assisted Orthopedic Surgery System Market, Global, 2024
- Figure 11-1: Robotic-Assisted Orthopedic Surgery System Procedure Segmentation
- Figure 11-2: Robotic-Assisted Orthopedic Surgery System Market Segmentation
- Figure 11-3: Robotic-Assisted Orthopedic Surgery System Regions Covered, Global (1 of 2)
- Figure 11-4: Robotic-Assisted Orthopedic Surgery System Regions Covered, Global (2 of 2)
- Figure 11-5: Robotic-Assisted Orthopedic Surgery Procedures by Anatomy, Global, 2021 – 2031
- Figure 11-6: Robotic-Assisted Orthopedic Surgery Procedures by Region, Global, 2021 – 2031
- Figure 11-7: Robotic-Assisted Orthopedic Surgery Procedures by Country, North America, 2021 – 2031
- Figure 11-8: Robotic-Assisted Orthopedic Surgery Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 11-9: Robotic-Assisted Orthopedic Surgery Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 11-10: Robotic-Assisted Orthopedic Surgery Procedures by Country, Western Europe, 2021 – 2031
- Figure 11-11: Robotic-Assisted Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 11-12: Robotic-Assisted Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 11-13: Robotic-Assisted Orthopedic Surgery Procedures by Country, Middle East, 2021 – 2031
- Figure 11-14: Robotic-Assisted Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 11-15: Robotic-Assisted Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 11-16: Robotic-Assisted Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 11-17: Robotic-Assisted Orthopedic Surgery Procedures by Country, Africa, 2021 – 2031
- Figure 11-18: Robotic-Assisted TKA Orthopedic Surgery Procedures by Region, Global, 2021 – 2031
- Figure 11-19: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, North America, 2021 – 2031
- Figure 11-20: Robotic-Assisted Orthopedic TKA Surgery Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 11-21: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 11-22: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Western Europe, 2021 – 2031
- Figure 11-23: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 11-24: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 11-25: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Middle East, 2021 – 2031
- Figure 11-26: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 11-27: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 11-28: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 11-29: Robotic-Assisted TKA Orthopedic Surgery Procedures by Country, Africa, 2021 – 2031
- Figure 11-30: Robotic-Assisted PKA Orthopedic Surgery Procedures by Region, Global, 2021 – 2031
- Figure 11-31: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, North America, 2021 – 2031
- Figure 11-32: Robotic-Assisted Orthopedic PKA Surgery Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 11-33: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 11-34: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Western Europe, 2021 – 2031
- Figure 11-35: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 11-36: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 11-37: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Middle East, 2021 – 2031
- Figure 11-38: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 11-39: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 11-40: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 11-41: Robotic-Assisted PKA Orthopedic Surgery Procedures by Country, Africa, 2021 – 2031
- Figure 11-42: Robotic-Assisted THA Orthopedic Surgery Procedures by Region, Global, 2021 – 2031
- Figure 11-43: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, North America, 2021 – 2031
- Figure 11-44: Robotic-Assisted Orthopedic THA Surgery Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 11-45: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 11-46: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Western Europe, 2021 – 2031
- Figure 11-47: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 11-48: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 11-49: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Middle East, 2021 – 2031
- Figure 11-50: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 11-51: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 11-52: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 11-53: Robotic-Assisted THA Orthopedic Surgery Procedures by Country, Africa, 2021 – 2031
- Figure 11-54: Robotic-Assisted Orthopedic Surgery System Market by Segment, Global, 2021 – 2031 (US$M)
- Figure 11-55: Robotic-Assisted Orthopedic Surgery System Market by Region, Global, 2021 – 2031 (US$M)
- Figure 11-56: System Placement, Robotic-Assisted Orthopedic Surgery System Market, Global, 2021 – 2031
- Figure 11-57: Total Systems Placed, Robotic-Assisted Orthopedic Surgery System Market, Global, 2021 – 2031
- Figure 11-58: System Leased or Placed under Financial Arrangement, Robotic-Assisted Neurosurgery System Market, Global, 2021 – 2031
- Figure 11-59: Robotic-Assisted Neurosurgery Capital Equipment Market, Global, 2021 – 2031
- Figure 11-60: Systems Sold by Region, Robotic-Assisted Orthopedic Surgery Capital Equipment Market, Global, 2021 – 2031
- Figure 11-61: Installed Base by Region, Robotic-Assisted Orthopedic Surgery Capital Equipment Market, Global, 2021 – 2031
- Figure 11-62: Average Selling Price by Region, Robotic-Assisted Orthopedic Surgery Capital Equipment Market, Global, 2021 – 2031 (US$)
- Figure 11-63: Market Value by Region, Robotic-Assisted Orthopedic Surgery Capital Equipment Market, Global, 2021 – 2031 (US$M)
- Figure 11-64: Robotic-Assisted Orthopedic Surgery Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 11-65: Procedures by Region, Robotic-Assisted Orthopedic Surgery Disposables and Other Accessories Market, Global, 2021 – 2031
- Figure 11-66: Average Selling Price by Region, Robotic-Assisted Orthopedic Surgery Disposables and Other Accessories Market, Global, 2021 – 2031 (US$)
- Figure 11-67: Market Value by Region, Robotic-Assisted Orthopedic Surgery Disposables and Other Accessories Market, Global, 2021 – 2031 (US$M)
- Figure 11-68: Robotic-Assisted Orthopedic Surgery Services and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 11-69: Installed Base Serviced by Region, Robotic-Assisted Orthopedic Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 11-70: Average Selling Price by Region, Robotic-Assisted Orthopedic Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031 (US$)
- Figure 11-71: Market Value by Region, Robotic-Assisted Orthopedic Surgery System Service and Maintenance Revenue Market, Global, 2021 – 2031
- Figure 11-72: Leading Competitors, Robotic-Assisted Orthopedic Surgery System Market, Global, 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
